New study reveals that toxic air can reshape gene activity in the brain, possibly creating the scene for Alzheimer’s and Parkinson, underlining the need for timely detection and stronger protection for workers at risk.
Review: Impact of air pollution and professional inhalation reports on neurodegenerative disorders: an epigenetic perspective. Credit Picture: Ingeblessas / Shutterstock
In a recent revision article published in the magazine drawResearchers in Italy explored how air pollution contributes to neurodegenerative disorders (NDS) through epigenetic modifications. They emphasized the possibility of using epigenetic indicators to detect early changes activated by air pollution, especially in high -risk groups. They emphasized the need for further research to guide professional and preventive health strategies.
Background
NDS are long -term diseases that include loss of nerve cells in the brain or nervous system, resulting in significant issues with memory, thinking, mood and physical function. Alzheimer’s disease and Parkinson’s disease are the most common, affecting millions of people worldwide. As age populations, the number of people under these conditions increases. Many cases are linked to risk factors that can be prevented, including bad lifestyle habits, low education or income and exposure to environmental pollution.
Air pollution consists of harmful particles and gases from natural sources, such as fires and human activities, including fuel combustion, traffic and factory emissions. The particles can carry toxic substances, including heavy metals, bacteria and volatile chemicals. Although mainly related to heart and pulmonary diseases, air pollution is now associated with brain damage and increased risk of NDS. Some workers, such as miners, workers and drivers, may be particularly risky.
How air pollution affects the brain
Air pollution can affect brain health through two primary pathways: direct and indirect. The immediate pathway includes excellent fine particles and some gases that can enter the bloodstream or travel through the nose to the brain, possibly destroy the blood -brain barrier (BBB) ​​and cause inflammation. Some pollutants, such as nitrogen dioxide (NO₂), are converted into drastic compounds that affect brain function, while others, such as volatile organic compounds (VOC), can accumulate in brain tissue due to their fat. Although the elements of direct brain effects of these pollutants remain limited, studies have shown that substances such as nanoplasts, lead and manganese can cross the BBB and damage the brain cells.
The indirect pathway includes pollutants that cause inflammation or chemical signals (such as cytokines, extracellular vesicles or lung/brain extracurricular) in organs such as lungs or intestine. These molecules then travel through the bloodstream to the brain, disrupting its balance and possibly leading to cognitive and emotional problems. Air pollution can also disrupt intestines and nasal germs, affecting brain health through intestinal axes or olfactory-brain. While experimental elements are still emerging, understanding of these mechanisms can help identify early biomarkers of pollution -related brain damage, especially in risk of populations such as workers in contaminated environments.
Epigenetic roads
Epigene changes regulate brain function without altering deoxyribonucleic acid sequences (DNA). These changes are vital to brain development, synaptic plasticity and memory, but they are also sensitive to environmental reports, such as air pollution. Chronic exposure to pollutants can disrupt these epigenetic processes, possibly leading to NDS. Evidence shows that this report can increase the expression of harmful genes, reduce the activity of protective genes, and alter the ribonucular acids (RNAS). These changes may occur long before symptoms occur, pointing out the epigenetic as a risk factor and an early biomarker for the NDS.
Airborne pollutants can disrupt brain function by altering non -coding rnas and DNA methylation, both of which regulate gene expression. Animal and human studies show that these changes are linked to memory loss, inflammation and NDS. However, most human elements come from samples of peripheral blood, not brain tissue, limiting clinical interpretation. Toxins such as toluene, manganese and lead can reduce the activity of protective genes or increase the production of harmful proteins in the brain. Some results can even be transferred to offspring. Atmospheric pollution also changes the methylation of DNA in the blood and brain tissue, possibly increasing the risk of life during life, especially with early or long -term exposure.
Few studies have explored how air pollution affects tissue modifications to neurodegenerative diseases (NDS) due to technical challenges. However, the first findings show links between air pollution and altered tissue indicators, DNA damage and Alzheimer’s disease pathology in both humans and mice. Prenatal exposure to particles affects brain growth, especially in men, due to reduced adhesive tissue, highlighting gender -related vulnerabilities. Plastic particles and heavy metals also disturb the tissue modifications, causing oxidative stress, memory loss and neurophympant. Specifically, some experimental elements for tissue modifications (eg changes caused by manganese) come from infusion -based studies rather than inhalation exposure, creating uncertainty about the risk of inhalation of real world. Inhibitors of tissue degeneration and compounds such as butyric (studied in lead mice) show potential to reversing some of these results, offering roads for future ND treatments.
Conclusions
Recent research shows strong bonds between air pollution and NDs mainly through epigenetic changes. Pollutants can alter DNA methylation, non -coding RNA expression and tissue modifications, which contribute to inflammation and brain damage. New methods such as the analysis of extracellular blood cells in the blood can help detect these changes without invasive procedures. However, the study of tissue modifications remains technically provocative. There are large gaps. The air pollution of the real world is complex, making it difficult to study accurate results. Factors such as particle size, individual health and exposure to early life affect the risk, but are not fully understood. Anatomical differences between animal models and humans (eg nasal structure) further complicate the translation of inhalation studies. Most studies focus on older adults, short -term exposure and limited number of pollutants, overlooking long -term and early effects. Diseases such as multiple sclerosis, amyotrophic lateral sclerosis (ALS) and Huntington’s disease are also under -selected.
Future studies should be long -term, include younger populations and examine less pollutants and exposure paths, such as diet or brain interactions. The combination of Omics and artificial intelligence technologies could help detect biomarkers and lead to the development of preventive treatments. Improved work and environmental protections, especially for high -risk groups, are also essential to reduce the risk of ND. The treatment of regulatory impacts requires the validation of epignetic tools for clinical use.
